373 related articles for article (PubMed ID: 33503958)
1. The Potentiation of Anti-Tumor Immunity by Tumor Abolition with Alpha Particles, Protons, or Carbon Ion Radiation and Its Enforcement by Combination with Immunoadjuvants or Inhibitors of Immune Suppressor Cells and Checkpoint Molecules.
Keisari Y; Kelson I
Cells; 2021 Jan; 10(2):. PubMed ID: 33503958
[TBL] [Abstract][Full Text] [Related]
2. Reduction of Lung Metastases in a Mouse Osteosarcoma Model Treated With Carbon Ions and Immune Checkpoint Inhibitors.
Helm A; Tinganelli W; Simoniello P; Kurosawa F; Fournier C; Shimokawa T; Durante M
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):594-602. PubMed ID: 32980497
[TBL] [Abstract][Full Text] [Related]
3. Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy.
Gorbet MJ; Ranjan A
Pharmacol Ther; 2020 Mar; 207():107456. PubMed ID: 31863820
[TBL] [Abstract][Full Text] [Related]
4. Are charged particles a good match for combination with immunotherapy? Current knowledge and perspectives.
Helm A; Totis C; Durante M; Fournier C
Int Rev Cell Mol Biol; 2023; 376():1-36. PubMed ID: 36997266
[TBL] [Abstract][Full Text] [Related]
5. The future of radiation-induced abscopal response: beyond conventional radiotherapy approaches.
Tubin S; Yan W; Mourad WF; Fossati P; Khan MK
Future Oncol; 2020 Jun; 16(16):1137-1151. PubMed ID: 32338046
[TBL] [Abstract][Full Text] [Related]
6. Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors.
Derer A; Frey B; Fietkau R; Gaipl US
Cancer Immunol Immunother; 2016 Jul; 65(7):779-86. PubMed ID: 26590829
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
Esposito A; Criscitiello C; Curigliano G
Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
[TBL] [Abstract][Full Text] [Related]
8. Carbon ion irradiation plus CTLA4 blockade elicits therapeutic immune responses in a murine tumor model.
Hartmann L; Osen W; Eichmüller OL; Kordaß T; Furkel J; Dickes E; Reid C; Debus J; Brons S; Abdollahi A; Moustafa M; Rieken S; Eichmüller SB
Cancer Lett; 2022 Dec; 550():215928. PubMed ID: 36183858
[TBL] [Abstract][Full Text] [Related]
9.
Cheng Y; Lemke-Miltner CD; Wongpattaraworakul W; Wang Z; Chan CHF; Salem AK; Weiner GJ; Simons AL
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33060147
[TBL] [Abstract][Full Text] [Related]
10. The Abscopal Effect: A Review of Pre-Clinical and Clinical Advances.
Janopaul-Naylor JR; Shen Y; Qian DC; Buchwald ZS
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681719
[TBL] [Abstract][Full Text] [Related]
11. Immunoadjuvants for cancer immunotherapy: A review of recent developments.
Banstola A; Jeong JH; Yook S
Acta Biomater; 2020 Sep; 114():16-30. PubMed ID: 32777293
[TBL] [Abstract][Full Text] [Related]
12. Combination of radiotherapy and immune checkpoint inhibitors.
Pilones KA; Vanpouille-Box C; Demaria S
Semin Radiat Oncol; 2015 Jan; 25(1):28-33. PubMed ID: 25481263
[TBL] [Abstract][Full Text] [Related]
13. Activation of local and systemic anti-tumor immune responses by ablation of solid tumors with intratumoral electrochemical or alpha radiation treatments.
Keisari Y; Hochman I; Confino H; Korenstein R; Kelson I
Cancer Immunol Immunother; 2014 Jan; 63(1):1-9. PubMed ID: 23955682
[TBL] [Abstract][Full Text] [Related]
14. In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment.
Vanpouille-Box C; Pilones KA; Wennerberg E; Formenti SC; Demaria S
Vaccine; 2015 Dec; 33(51):7415-7422. PubMed ID: 26148880
[TBL] [Abstract][Full Text] [Related]
15. Phy-X/ZeXTRa: a software for robust calculation of effective atomic numbers for photon, electron, proton, alpha particle, and carbon ion interactions.
Özpolat ÖF; Alım B; Şakar E; Büyükyıldız M; Kurudirek M
Radiat Environ Biophys; 2020 May; 59(2):321-329. PubMed ID: 31960126
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the immune responses in cancer cells irradiated with X-ray, proton and carbon-ion beams.
Du J; Kageyama SI; Hirata H; Motegi A; Nakamura M; Hirano Y; Okumura M; Yamashita R; Tsuchihara K; Hojo H; Hirayama R; Akimoto T
Biochem Biophys Res Commun; 2021 Dec; 585():55-60. PubMed ID: 34784552
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in light ion radiation therapy.
Brahme A
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):603-16. PubMed ID: 14751534
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity.
Donlon NE; Power R; Hayes C; Reynolds JV; Lysaght J
Cancer Lett; 2021 Apr; 502():84-96. PubMed ID: 33450360
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Tregs on the Anticancer Immunity and the Efficacy of Immune Checkpoint Inhibitor Therapies.
González-Navajas JM; Fan DD; Yang S; Yang FM; Lozano-Ruiz B; Shen L; Lee J
Front Immunol; 2021; 12():625783. PubMed ID: 33717139
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade.
Chuang YC; Tseng JC; Huang LR; Huang CM; Huang CF; Chuang TH
Front Immunol; 2020; 11():1075. PubMed ID: 32547560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
